Waypoint Biomedical 

$0.000200
5
-$0.00-66.67%Tuesday 15:47

Statistics

Day High
0.0006
Day Low
0.0006
52W High
0.002
52W Low
0.0002
Volume
5,000
Avg. Volume
1,564
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap88.52B
Moderna is a leader in mRNA technology, directly competing with Waypoint Biomedical's focus on innovative biomedical solutions.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a large pharmaceutical company with a broad range of products that compete in the same market as Waypoint Biomedical's healthcare solutions.
BioNTech
BNTX
Mkt Cap22.15B
BioNTech partners with companies like Pfizer to develop vaccines and therapies that could directly compete with Waypoint Biomedical's product offerings.
Novavax
NVAX
Mkt Cap1.66B
Novavax is involved in the development of vaccines for infectious diseases, competing with Waypoint Biomedical's research and development in similar areas.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson is a diversified healthcare giant that competes across various segments, including pharmaceuticals and medical devices, overlapping with Waypoint Biomedical's market.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories offers a wide range of healthcare products that compete with Waypoint Biomedical's diagnostics and medical devices.
AMGEN
AMGN
Mkt Cap251.94B
Amgen focuses on human therapeutics, including treatments for illnesses in areas that Waypoint Biomedical may also be targeting.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences is known for its antiviral drugs, directly competing with Waypoint Biomedical's efforts in developing treatments for infectious diseases.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals specializes in the invention of medicines for serious diseases, potentially competing with Waypoint Biomedical's innovative healthcare solutions.
Vertex Pharmaceuticals
VRTX
Mkt Cap141.65B
Vertex Pharmaceuticals is focused on creating new possibilities in medicine to cure diseases and improve people's lives, competing with Waypoint Biomedical's mission and product lines.

About

WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
Show More
CEO
Steven Fox
Employees
1
Country
United States
ISIN
US9467552041

Listings

0 Comments

Share your thoughts

FAQs

What is Waypoint Biomedical stock price today?▼
The current price of WYPH is $0.00 USD — it has decreased by -66.67% in the past 24 hours. Watch Waypoint Biomedical stock price performance more closely on the chart.
What is Waypoint Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Waypoint Biomedical stocks are traded under the ticker WYPH.
Is Waypoint Biomedical stock price growing?▼
WYPH stock has fallen by -66.67% compared to the previous week, the month change is a -60% fall, over the last year Waypoint Biomedical has showed a +0% increase.
How many employees does Waypoint Biomedical have?▼
As of November 2, 2026, the company has 1 employees.
In which sector is Waypoint Biomedical located?▼
Waypoint Biomedical operates in the Manufacturing sector.
When did Waypoint Biomedical complete a stock split?▼
Waypoint Biomedical has not had any recent stock splits.
Where is Waypoint Biomedical headquartered?▼
Waypoint Biomedical is headquartered in Huntington Beach, United States.